AAH2

Toxoplasma gondii AAH2 encodes an aromatic amino acid hydroxylase that produces L-DOPA from phenylalanine, a precursor implicated in melanins, secondary quinones, and dityrosine protein crosslinks relevant to oocyst wall biology; its predominant established role is in the parasite's sexual reproductive cycle in the feline definitive host, where deletion of AAH genes reduces cat infection, oocyst yield, and sporulation rates (PMID:28288194). Expression is restricted to the bradyzoite stage, as shown by stage-specific eGFP-tagged AAH2 localization in vitro and in chronically infected mice (PMID:30876436). AAH2 is dispensable for asexual biology: its loss produces no growth or differentiation phenotype in tachyzoites or bradyzoites, and its overexpression does not alter host brain dopamine (PMID:25547791); deletion neither rescues the growth defect of tachyzoites under tyrosine-limiting conditions (PMID:28257757) nor is required for infection-induced dopamine-dependent neurobehavioral changes or neuroinflammation in mice (PMID:29555339). Beyond these genetic and localization studies, no structural or enzymatic-mechanistic detail of AAH2 has been characterized in the available corpus.

1. 2014 Medium

   To test the long-standing hypothesis that a parasite aromatic amino acid hydroxylase drives host dopamine changes, AAH2 was knocked out and overexpressed and host brain dopamine measured, establishing that AAH2 is not required for global or regional dopamine alterations.

   Evidence AAH2 knockout, complementation, and BAG1-promoter overexpression with host brain dopamine measurement in vitro and in vivo

   PMID:25547791

   Open questions at the time

   • Does not identify what AAH2 does contribute to in the parasite life cycle
   • Does not assess enzymatic activity of AAH2 directly
2. 2017 Medium

   To assign a definitive biological role, AAH gene knockouts were assayed in the feline host, revealing that AAH-derived L-DOPA production is predominantly needed for sexual reproduction, with reduced cat infection, oocyst yield, and sporulation.

   Evidence Genetic knockout of AAH1 and AAH2 with in vivo cat infection measuring oocyst yield and sporulation

   PMID:28288194

   Open questions at the time

   • Combined AAH1/AAH2 phenotype does not isolate AAH2's individual contribution
   • Direct biochemical demonstration of L-DOPA's role in oocyst wall crosslinking not shown
   • Molecular mechanism connecting L-DOPA to wall biology not established
3. 2017 Medium

   To test whether AAH2 supports parasite amino acid needs, deletion strains were grown under limiting tyrosine, showing AAH2-mediated tyrosine synthesis from phenylalanine is insufficient to rescue tachyzoite growth.

   Evidence Plaque assays of wild-type and Δaah2 parasites in tyrosine-titrated media

   PMID:28257757

   Open questions at the time

   • Does not measure AAH2 catalytic output quantitatively
   • Does not address whether AAH2 supports tyrosine needs in other stages
4. 2018 Medium

   To directly test AAH2's role in behavioral manipulation, deletion strains were assayed for dopamine-dependent neurobehavioral abnormalities and neuroinflammation in mice, confirming AAH2 is not required for these dopaminergic alterations.

   Evidence Δaah2 vs wild-type infection of BALB/c mice with amphetamine/cocaine behavioral testing, DAT/VMAT2 blots and immunohistochemistry, neuroinflammation assessment

   PMID:29555339

   Open questions at the time

   • Does not identify the source of infection-induced dopaminergic changes
   • Restricted to BALB/c background
5. 2019 Low

   To localize AAH2 within the parasite life cycle, eGFP-tagged AAH2 was imaged, establishing bradyzoite-stage-specific expression consistent with a role during chronic/differentiated stages.

   Evidence TALEN-mediated eGFP tagging with fluorescence imaging in vitro and in vivo in chronically infected mice (PRU strain)

   PMID:30876436

   Open questions at the time

   • Single localization experiment with no functional consequence linked to localization
   • Subcellular localization within the bradyzoite not resolved
   • Not linked mechanistically to the oocyst/sexual-cycle phenotype

• The biochemical mechanism by which AAH2-derived L-DOPA contributes to oocyst wall formation and sporulation, and AAH2's individual (versus AAH1-shared) enzymatic contribution, remain unresolved.
• No structural or purified-enzyme kinetic characterization of AAH2
• Direct link between L-DOPA and dityrosine/melanin crosslinking in the oocyst wall not demonstrated
• AAH2-specific contribution not separated from AAH1